Liver Abscess in Advanced Hepatocellular Carcinoma after Sorafenib Treatment / 대한소화기학회지
The Korean Journal of Gastroenterology
;
: 47-50, 2014.
Artículo
en Inglés
| WPRIM
| ID: wpr-87789
ABSTRACT
Hepatocellular carcinoma (HCC) is a critical global health issue and the third most common cause of cancer-related deaths worldwide. The majority of patients who present HCC are already at an advanced stage and their tumors are unresectable. Sorafenib is a multi-kinase inhibitor of the vascular endothelial growth factor pathway and was recently introduced as a therapy for advanced HCC. Furthermore, studies have shown that oral sorafenib has beneficial effects on survival. However, many patients experience diverse side effects, and some of these are severe. Liver abscess development has not been previously documented to be associated with sorafenib administration in HCC. Here, we report the case of a HCC patient that developed a liver abscess while being treated with sorafenib.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Compuestos de Fenilurea
/
Tomografía Computarizada por Rayos X
/
Clostridium
/
Infecciones por Clostridium
/
Niacinamida
/
Carcinoma Hepatocelular
/
Absceso Hepático
/
Neoplasias Hepáticas
/
Antibacterianos
/
Antineoplásicos
Límite:
Humanos
/
Masculino
Idioma:
Inglés
Revista:
The Korean Journal of Gastroenterology
Año:
2014
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS